Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 16, 2026

Novel and Innovative Hybrid Technique for Type A Aortic Dissection
06:26

Novel and Innovative Hybrid Technique for Type A Aortic Dissection

Published on: March 28, 2025

Thoracic endovascular aortic repair for type B aortic dissection.

Houssam K Younes1, Patricia W Harris, Jean Bismuth

  • 1Department of Cardiovascular Surgery, Methodist DeBakey Heart and Vascular Center and The Methodist Hospital Research Institute, The Methodist Hospital, Houston, 6550 Fannin Street, Smith TowereSuite 1401, Houston, TX 77030, USA.

Annals of Vascular Surgery
|February 4, 2010
PubMed
Summary

Related Concept Videos

Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction to: 2025 ACC/AHA/ASE/ASNC/SCCT/SCMR Advanced Training Statement on Advanced Cardiovascular Imaging: A Report of the ACC Competency Management Committee.

Circulation. Cardiovascular imaging·2026
Same author

Cerebral Microembolization Generated by Percutaneously Implanted Microaxial Left Ventricular Assist Device.

Journal of cardiothoracic and vascular anesthesia·2026
Same author

Feasibility of optical coherence tomography for localizing and quantifying paclitaxel deposition after drug-coated balloon angioplasty.

International journal of cardiology·2026
Same author

Retrograde type A aortic dissection following endovascular arch repair: what do clinicians need to be aware of?

Expert review of cardiovascular therapy·2026
Same author

Reply.

Journal of vascular surgery·2026
Same author

Endovascular aortic retrieval of migrated iliac stent.

Journal of vascular surgery cases and innovative techniques·2026

Thoracic endovascular aortic repair (TEVAR) offers improved outcomes for aortic dissection but still presents significant morbidity. Understanding these morbidity patterns is crucial for optimizing patient care and treatment strategies in complex aortic diseases.

Area of Science:

  • Vascular Surgery
  • Interventional Cardiology
  • Thoracic Surgery

Background:

  • Thoracic endovascular aortic repair (TEVAR) is an emerging off-label treatment for aortic dissection.
  • This study reports on TEVAR experience, focusing on morbidity patterns in aortic dissection patients.

Purpose of the Study:

  • To evaluate the outcomes and morbidity associated with TEVAR in patients with thoracic aortic disease, specifically aortic dissection.
  • To define the patterns of morbidity following TEVAR for aortic dissection.

Main Methods:

  • Retrospective review of 90 patients undergoing TEVAR (Feb 2005-Dec 2007).
  • Focus on 17 patients with type B aortic dissection.
  • Analysis of patient demographics, presentation, procedural details, and postoperative outcomes.

Related Experiment Videos

Last Updated: Jun 16, 2026

Novel and Innovative Hybrid Technique for Type A Aortic Dissection
06:26

Novel and Innovative Hybrid Technique for Type A Aortic Dissection

Published on: March 28, 2025

Main Results:

  • 100% technical success with TEVAR in the studied cohort.
  • 30-day mortality was 5.5%, with overall morbidity at 12%.
  • Key complications included respiratory failure (28%), gastrointestinal symptoms (11%), and transient spinal cord ischemia (5.5%).

Conclusions:

  • TEVAR has improved outcomes for aortic dissection but remains associated with considerable morbidity.
  • Distinct morbidity patterns exist based on presentation mode and anatomical extent of the dissection.